Neurokinin Receptor Antagonist Associated to Ondansetron in PONV

• Status: Completed
• Trial end date: 2015-08-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to determine whether patients at high risk for postoperative nausea and vomiting can benefit from aprepitant, ondansetron and dexamethasone in the perioperative period.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Instituto do Cancer do Estado de São Paulo
• Treatments: Aprepitant; Fosaprepitant; Neurokinin A; Neurokinin-1 Receptor Antagonists; Ondansetron

Criteria

Inclusion Criteria:

• high risk patients for nausea and vomiting

Exclusion Criteria:

• cardiovascular disease, or hypersensibility to any of the drugs involved in the study